HARARE – CAPS Holdings, Zimbabwe’s largest pharmaceutical group, urgently requires $6 million in recapitalisation funds, with the drug-maker currently operating at five percent of installed capacity. Government assumed control of the stuttering drug-maker in August after buying out ex-major shareholder Frederick Mtandah. [GoogleAd] This was after CAPS’ faced a critical funding shortfall, with its property…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions